To make provision about the evaluation of methods of testing the safety of medicines; and for connected purposes
The Bill proposes the establishment of a Medicines Safety Evaluation Panel to compare the effectiveness of human biology-based tests and animal-based tests in assessing the safety of medicines and drugs. The panel would be required to report within two years and would have full access to all relevant records held by the Medicines and Healthcare Products Regulatory Agency.
House of Commons
30 October 2008
May contain errors — check source documents for definitive information.
This bill would set up a Medicines Safety Evaluation Panel to compare human biology-based safety tests with animal-based tests used for medicines. The panel would report its findings within two years and would have full access to relevant records held by the Medicines and Healthcare products Regulatory Agency. Its work could influence how safety testing for medicines is conducted in future.
The bill is currently at the Second Reading stage in the House of Commons. It originated in the Commons, with its first reading in July 2008.
Generated 21 February 2026
10 Jul 2008
No recorded votes for this bill yet.
